vimarsana.com

Latest Breaking News On - Point pharmaceuticals stock down - Page 1 : vimarsana.com

Brokerages Set EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) Price Target at $33 86

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has received an average recommendation of “Buy” from the seven brokerages that are presently covering the stock, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year […]

Legato Capital Management LLC Has $1 37 Million Stake in EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT)

Legato Capital Management LLC lessened its holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 23.3% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 59,347 shares of the company’s stock after selling 18,054 shares during the period. Legato Capital Management LLC owned […]

Legato Capital Management LLC Sells 18,054 Shares of EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT)

Legato Capital Management LLC trimmed its holdings in shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 23.3% during the fourth quarter, HoldingsChannel reports. The fund owned 59,347 shares of the company’s stock after selling 18,054 shares during the quarter. Legato Capital Management LLC’s holdings in EyePoint Pharmaceuticals were worth $1,372,000 at the end […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.